4930451C15Rik Inhibitors

The chemical class known as LRRC74B inhibitors is not a well-defined class due to the lack of direct inhibitors for the LRRC74B protein. The compounds listed above are associated with various signaling pathways known to be influenced by leucine-rich repeat (LRR) containing proteins in general. These compounds form a diverse group, including small molecule inhibitors that target key signaling molecules such as kinases, phosphatases, and proteases. The rationale behind selecting these compounds is to affect the signaling pathways that the LRRC74B protein may be a part of, thus indirectly influencing its function.

Compounds such as IWP-2, XAV939, and Cyclopamine target key components in the Wnt, β-catenin, and Hedgehog signaling pathways, respectively, which are common pathways known to interact with LRR-containing proteins. Inhibiting these pathways can modulate the overall signaling environment, possibly affecting the function of LRRC74B. Other compounds like U0126, SB203580, LY294002, Rapamycin, SP600125, DAPT, BAY 11-7082, PD98059, and TPCA-1 act on the MAPK, PI3K/Akt, mTOR, JNK, Notch, NF-κB, and IKK signaling pathways. These pathways are central to controlling cell growth, proliferation, differentiation, and survival, processes in which LRRC74B might be indirectly involved.